top of page

F&A – Where the Action Is

The foot and ankle market segment is now, for the first time, considered one of the most lucrative orthopedic segments.

$2-$5 billion, annually

Current estimates put the U.S and worldwide foot and ankle market shares north of $2 billion, and $5 billion, respectively. Annual growth rates are equally as impressive, ranging from 6% to 10%, according to the "Foot And Ankle Devices Global Market Report 2022."


Consolidation will continue

Stryker's acquisition of Wright Medical started the trend. Envois, DePuy Synthes, ConMed, Medartis, and Acumed all followed suit with acquisitions of their own, further setting the stage.


Competition is good

  • Patient-specific implants/guides

  • Intraoperative guidance systems

  • Renewed interest in minimally invasive surgery

  • New bioabsorbable implants that may supplant traditional fixation

  • Novel closure innovations

Contentious competition is all but certain.

Recent Posts

See All

The Gloves Are Off

David (niche bunion company Treace Medical Concepts ) takes on Goliath ( Stryker Corporation ) with a newly announced  lawsuit , alleging...

Exactech Declares Bankruptcy

Exactech, founded by orthopedic surgeon Dr. Bill Petty in 1985, evolved into a big player in the orthopedic space, achieving revenues of...

Malpractice Litigation and Hindfoot Fusion

by Vince Vacketta, DPM Medical malpractice litigation is an unfortunate aspect of any physician’s or surgeon's practice. Orthopedic...

Comentários


FIX Masthead 2000x318 v2.jpg
bottom of page